Loading…
The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory [CD4.sup.+] T cells
Despite long-term antiretroviral therapy (ART), HIV-1 persists within a reservoir of [CD4.sup.+] T cells that contribute to viral rebound if treatment is interrupted. Identifying the cellular populations that contribute to the HIV-1 reservoir and understanding the mechanisms of viral persistence are...
Saved in:
Published in: | The Journal of clinical investigation 2022-04, Vol.132 (7) |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 7 |
container_start_page | |
container_title | The Journal of clinical investigation |
container_volume | 132 |
creator | Duette, Gabriel Hiener, Bonnie Morgan, Hannah Mazur, Fernando G Mathivanan, Vennila Horsburgh, Bethany A Fisher, Katie Tong, Orion Lee, Eunok Ahn, Haelee Shaik, Ansari Fromentin, Remi Hoh, Rebecca Bacchus-Souffan, Charline Nasr, Najla Cunningham, Anthony L Hunt, Peter W Chomont, Nicolas Turville, Stuart G Deeks, Steven G Kelleher, Anthony D Schlub, Timothy E Palmer, Sarah |
description | Despite long-term antiretroviral therapy (ART), HIV-1 persists within a reservoir of [CD4.sup.+] T cells that contribute to viral rebound if treatment is interrupted. Identifying the cellular populations that contribute to the HIV-1 reservoir and understanding the mechanisms of viral persistence are necessary to achieve an effective cure. In this regard, through Full-Length Individual Proviral Sequencing, we observed that the HIV-1 proviral landscape was different and changed with time on ART across naive and memory [CD4.sup.+] T cell subsets isolated from 24 participants. We found that the proportion of genetically intact HIV-1 proviruses was higher and persisted over time in effector memory [CD4.sup.+] T cells when compared with naive, central, and transitional memory [CD4.sup.+] T cells. Interestingly, we found that escape mutations remained stable over time within effector memory T cells during therapy. Finally, we provided evidence that Nef plays a role in the persistence of genetically intact HIV-1. These findings posit effector memory T cells as a key component of the HIV-1 reservoir and suggest Nef as an attractive therapeutic target. |
doi_str_mv | 10.1172/JCI154422 |
format | article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A700177931</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A700177931</galeid><sourcerecordid>A700177931</sourcerecordid><originalsourceid>FETCH-LOGICAL-g2041-68531803403c931b6b1857d680927f4964636e1928889b3b59ffb465cc9f10fb3</originalsourceid><addsrcrecordid>eNqNkV9LwzAUxYMoOKcPfoOAIIi0Jk3apo8y_6wyHOjci8hos5su0jWjSYd-eyMqbLAHuQ8XDr9zHs5B6JSSkNI0unoY5DTmPIr2UI_GsQhExMQ-6hES0SBLmThER9a-E0I5j3kPdZMF4GE-DShetWat26LGddHMrSxWgFtYQ1Fb7BaFw4-gsDSNa3XZOfCi-TNCa7V10EjAusGgFEhnWryEpWk_8evghoe2W4WXb3iCJdS1PUYHyufCye_vo5e728lgGIzG9_ngehRUEeE0SETMqCCMEyYzRsukpCJO54kgWZQqniU8YQnQLBJCZCUr40ypkiexlJmiRJWsj85-cquihplulHFtIZfaytl16jtIUx_rqWAHVUEDvg3TgNJe3uLDHby_OSy13Gm42DJ8twgfrio6a2f589P_2fF0mz3fYBd-Krewpu6cNo3dBL8AKOegyg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory [CD4.sup.+] T cells</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Duette, Gabriel ; Hiener, Bonnie ; Morgan, Hannah ; Mazur, Fernando G ; Mathivanan, Vennila ; Horsburgh, Bethany A ; Fisher, Katie ; Tong, Orion ; Lee, Eunok ; Ahn, Haelee ; Shaik, Ansari ; Fromentin, Remi ; Hoh, Rebecca ; Bacchus-Souffan, Charline ; Nasr, Najla ; Cunningham, Anthony L ; Hunt, Peter W ; Chomont, Nicolas ; Turville, Stuart G ; Deeks, Steven G ; Kelleher, Anthony D ; Schlub, Timothy E ; Palmer, Sarah</creator><creatorcontrib>Duette, Gabriel ; Hiener, Bonnie ; Morgan, Hannah ; Mazur, Fernando G ; Mathivanan, Vennila ; Horsburgh, Bethany A ; Fisher, Katie ; Tong, Orion ; Lee, Eunok ; Ahn, Haelee ; Shaik, Ansari ; Fromentin, Remi ; Hoh, Rebecca ; Bacchus-Souffan, Charline ; Nasr, Najla ; Cunningham, Anthony L ; Hunt, Peter W ; Chomont, Nicolas ; Turville, Stuart G ; Deeks, Steven G ; Kelleher, Anthony D ; Schlub, Timothy E ; Palmer, Sarah</creatorcontrib><description>Despite long-term antiretroviral therapy (ART), HIV-1 persists within a reservoir of [CD4.sup.+] T cells that contribute to viral rebound if treatment is interrupted. Identifying the cellular populations that contribute to the HIV-1 reservoir and understanding the mechanisms of viral persistence are necessary to achieve an effective cure. In this regard, through Full-Length Individual Proviral Sequencing, we observed that the HIV-1 proviral landscape was different and changed with time on ART across naive and memory [CD4.sup.+] T cell subsets isolated from 24 participants. We found that the proportion of genetically intact HIV-1 proviruses was higher and persisted over time in effector memory [CD4.sup.+] T cells when compared with naive, central, and transitional memory [CD4.sup.+] T cells. Interestingly, we found that escape mutations remained stable over time within effector memory T cells during therapy. Finally, we provided evidence that Nef plays a role in the persistence of genetically intact HIV-1. These findings posit effector memory T cells as a key component of the HIV-1 reservoir and suggest Nef as an attractive therapeutic target.</description><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/JCI154422</identifier><language>eng</language><publisher>American Society for Clinical Investigation</publisher><subject>Antiviral agents ; Care and treatment ; Development and progression ; Genetic aspects ; Health aspects ; HIV (Viruses) ; HIV infection ; Immunologic memory ; Patient outcomes ; T cells ; Viral proteins</subject><ispartof>The Journal of clinical investigation, 2022-04, Vol.132 (7)</ispartof><rights>COPYRIGHT 2022 American Society for Clinical Investigation</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Duette, Gabriel</creatorcontrib><creatorcontrib>Hiener, Bonnie</creatorcontrib><creatorcontrib>Morgan, Hannah</creatorcontrib><creatorcontrib>Mazur, Fernando G</creatorcontrib><creatorcontrib>Mathivanan, Vennila</creatorcontrib><creatorcontrib>Horsburgh, Bethany A</creatorcontrib><creatorcontrib>Fisher, Katie</creatorcontrib><creatorcontrib>Tong, Orion</creatorcontrib><creatorcontrib>Lee, Eunok</creatorcontrib><creatorcontrib>Ahn, Haelee</creatorcontrib><creatorcontrib>Shaik, Ansari</creatorcontrib><creatorcontrib>Fromentin, Remi</creatorcontrib><creatorcontrib>Hoh, Rebecca</creatorcontrib><creatorcontrib>Bacchus-Souffan, Charline</creatorcontrib><creatorcontrib>Nasr, Najla</creatorcontrib><creatorcontrib>Cunningham, Anthony L</creatorcontrib><creatorcontrib>Hunt, Peter W</creatorcontrib><creatorcontrib>Chomont, Nicolas</creatorcontrib><creatorcontrib>Turville, Stuart G</creatorcontrib><creatorcontrib>Deeks, Steven G</creatorcontrib><creatorcontrib>Kelleher, Anthony D</creatorcontrib><creatorcontrib>Schlub, Timothy E</creatorcontrib><creatorcontrib>Palmer, Sarah</creatorcontrib><title>The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory [CD4.sup.+] T cells</title><title>The Journal of clinical investigation</title><description>Despite long-term antiretroviral therapy (ART), HIV-1 persists within a reservoir of [CD4.sup.+] T cells that contribute to viral rebound if treatment is interrupted. Identifying the cellular populations that contribute to the HIV-1 reservoir and understanding the mechanisms of viral persistence are necessary to achieve an effective cure. In this regard, through Full-Length Individual Proviral Sequencing, we observed that the HIV-1 proviral landscape was different and changed with time on ART across naive and memory [CD4.sup.+] T cell subsets isolated from 24 participants. We found that the proportion of genetically intact HIV-1 proviruses was higher and persisted over time in effector memory [CD4.sup.+] T cells when compared with naive, central, and transitional memory [CD4.sup.+] T cells. Interestingly, we found that escape mutations remained stable over time within effector memory T cells during therapy. Finally, we provided evidence that Nef plays a role in the persistence of genetically intact HIV-1. These findings posit effector memory T cells as a key component of the HIV-1 reservoir and suggest Nef as an attractive therapeutic target.</description><subject>Antiviral agents</subject><subject>Care and treatment</subject><subject>Development and progression</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>HIV (Viruses)</subject><subject>HIV infection</subject><subject>Immunologic memory</subject><subject>Patient outcomes</subject><subject>T cells</subject><subject>Viral proteins</subject><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqNkV9LwzAUxYMoOKcPfoOAIIi0Jk3apo8y_6wyHOjci8hos5su0jWjSYd-eyMqbLAHuQ8XDr9zHs5B6JSSkNI0unoY5DTmPIr2UI_GsQhExMQ-6hES0SBLmThER9a-E0I5j3kPdZMF4GE-DShetWat26LGddHMrSxWgFtYQ1Fb7BaFw4-gsDSNa3XZOfCi-TNCa7V10EjAusGgFEhnWryEpWk_8evghoe2W4WXb3iCJdS1PUYHyufCye_vo5e728lgGIzG9_ngehRUEeE0SETMqCCMEyYzRsukpCJO54kgWZQqniU8YQnQLBJCZCUr40ypkiexlJmiRJWsj85-cquihplulHFtIZfaytl16jtIUx_rqWAHVUEDvg3TgNJe3uLDHby_OSy13Gm42DJ8twgfrio6a2f589P_2fF0mz3fYBd-Krewpu6cNo3dBL8AKOegyg</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Duette, Gabriel</creator><creator>Hiener, Bonnie</creator><creator>Morgan, Hannah</creator><creator>Mazur, Fernando G</creator><creator>Mathivanan, Vennila</creator><creator>Horsburgh, Bethany A</creator><creator>Fisher, Katie</creator><creator>Tong, Orion</creator><creator>Lee, Eunok</creator><creator>Ahn, Haelee</creator><creator>Shaik, Ansari</creator><creator>Fromentin, Remi</creator><creator>Hoh, Rebecca</creator><creator>Bacchus-Souffan, Charline</creator><creator>Nasr, Najla</creator><creator>Cunningham, Anthony L</creator><creator>Hunt, Peter W</creator><creator>Chomont, Nicolas</creator><creator>Turville, Stuart G</creator><creator>Deeks, Steven G</creator><creator>Kelleher, Anthony D</creator><creator>Schlub, Timothy E</creator><creator>Palmer, Sarah</creator><general>American Society for Clinical Investigation</general><scope>IOV</scope><scope>ISR</scope></search><sort><creationdate>20220401</creationdate><title>The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory [CD4.sup.+] T cells</title><author>Duette, Gabriel ; Hiener, Bonnie ; Morgan, Hannah ; Mazur, Fernando G ; Mathivanan, Vennila ; Horsburgh, Bethany A ; Fisher, Katie ; Tong, Orion ; Lee, Eunok ; Ahn, Haelee ; Shaik, Ansari ; Fromentin, Remi ; Hoh, Rebecca ; Bacchus-Souffan, Charline ; Nasr, Najla ; Cunningham, Anthony L ; Hunt, Peter W ; Chomont, Nicolas ; Turville, Stuart G ; Deeks, Steven G ; Kelleher, Anthony D ; Schlub, Timothy E ; Palmer, Sarah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g2041-68531803403c931b6b1857d680927f4964636e1928889b3b59ffb465cc9f10fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antiviral agents</topic><topic>Care and treatment</topic><topic>Development and progression</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>HIV (Viruses)</topic><topic>HIV infection</topic><topic>Immunologic memory</topic><topic>Patient outcomes</topic><topic>T cells</topic><topic>Viral proteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Duette, Gabriel</creatorcontrib><creatorcontrib>Hiener, Bonnie</creatorcontrib><creatorcontrib>Morgan, Hannah</creatorcontrib><creatorcontrib>Mazur, Fernando G</creatorcontrib><creatorcontrib>Mathivanan, Vennila</creatorcontrib><creatorcontrib>Horsburgh, Bethany A</creatorcontrib><creatorcontrib>Fisher, Katie</creatorcontrib><creatorcontrib>Tong, Orion</creatorcontrib><creatorcontrib>Lee, Eunok</creatorcontrib><creatorcontrib>Ahn, Haelee</creatorcontrib><creatorcontrib>Shaik, Ansari</creatorcontrib><creatorcontrib>Fromentin, Remi</creatorcontrib><creatorcontrib>Hoh, Rebecca</creatorcontrib><creatorcontrib>Bacchus-Souffan, Charline</creatorcontrib><creatorcontrib>Nasr, Najla</creatorcontrib><creatorcontrib>Cunningham, Anthony L</creatorcontrib><creatorcontrib>Hunt, Peter W</creatorcontrib><creatorcontrib>Chomont, Nicolas</creatorcontrib><creatorcontrib>Turville, Stuart G</creatorcontrib><creatorcontrib>Deeks, Steven G</creatorcontrib><creatorcontrib>Kelleher, Anthony D</creatorcontrib><creatorcontrib>Schlub, Timothy E</creatorcontrib><creatorcontrib>Palmer, Sarah</creatorcontrib><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duette, Gabriel</au><au>Hiener, Bonnie</au><au>Morgan, Hannah</au><au>Mazur, Fernando G</au><au>Mathivanan, Vennila</au><au>Horsburgh, Bethany A</au><au>Fisher, Katie</au><au>Tong, Orion</au><au>Lee, Eunok</au><au>Ahn, Haelee</au><au>Shaik, Ansari</au><au>Fromentin, Remi</au><au>Hoh, Rebecca</au><au>Bacchus-Souffan, Charline</au><au>Nasr, Najla</au><au>Cunningham, Anthony L</au><au>Hunt, Peter W</au><au>Chomont, Nicolas</au><au>Turville, Stuart G</au><au>Deeks, Steven G</au><au>Kelleher, Anthony D</au><au>Schlub, Timothy E</au><au>Palmer, Sarah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory [CD4.sup.+] T cells</atitle><jtitle>The Journal of clinical investigation</jtitle><date>2022-04-01</date><risdate>2022</risdate><volume>132</volume><issue>7</issue><issn>0021-9738</issn><eissn>1558-8238</eissn><abstract>Despite long-term antiretroviral therapy (ART), HIV-1 persists within a reservoir of [CD4.sup.+] T cells that contribute to viral rebound if treatment is interrupted. Identifying the cellular populations that contribute to the HIV-1 reservoir and understanding the mechanisms of viral persistence are necessary to achieve an effective cure. In this regard, through Full-Length Individual Proviral Sequencing, we observed that the HIV-1 proviral landscape was different and changed with time on ART across naive and memory [CD4.sup.+] T cell subsets isolated from 24 participants. We found that the proportion of genetically intact HIV-1 proviruses was higher and persisted over time in effector memory [CD4.sup.+] T cells when compared with naive, central, and transitional memory [CD4.sup.+] T cells. Interestingly, we found that escape mutations remained stable over time within effector memory T cells during therapy. Finally, we provided evidence that Nef plays a role in the persistence of genetically intact HIV-1. These findings posit effector memory T cells as a key component of the HIV-1 reservoir and suggest Nef as an attractive therapeutic target.</abstract><pub>American Society for Clinical Investigation</pub><doi>10.1172/JCI154422</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9738 |
ispartof | The Journal of clinical investigation, 2022-04, Vol.132 (7) |
issn | 0021-9738 1558-8238 |
language | eng |
recordid | cdi_gale_infotracmisc_A700177931 |
source | EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Antiviral agents Care and treatment Development and progression Genetic aspects Health aspects HIV (Viruses) HIV infection Immunologic memory Patient outcomes T cells Viral proteins |
title | The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory [CD4.sup.+] T cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T07%3A55%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20HIV-1%20proviral%20landscape%20reveals%20that%20Nef%20contributes%20to%20HIV-1%20persistence%20in%20effector%20memory%20%5BCD4.sup.+%5D%20T%20cells&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Duette,%20Gabriel&rft.date=2022-04-01&rft.volume=132&rft.issue=7&rft.issn=0021-9738&rft.eissn=1558-8238&rft_id=info:doi/10.1172/JCI154422&rft_dat=%3Cgale%3EA700177931%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g2041-68531803403c931b6b1857d680927f4964636e1928889b3b59ffb465cc9f10fb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A700177931&rfr_iscdi=true |